Publications by authors named "Thomas A Colacchio"

Claim this Profile
E
Effect of intraoperative secretin on operative outcomes in pancreatic resection: A randomized controlled trial.
Kerrington D Smith, Richard J Barth, Thomas A Colacchio, Jessica I Chevalier, Lindsay E Bergmann

Pancreatology· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to L. Casadaban et al.
Donna Niedzwiecki, Wendy L Frankel, Alan P Venook, Xing Ye, Paula N Friedman, Thomas A Colacchio

J Clin Oncol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Study of Thymidylate Synthase Expression as a Biomarker for Resectable Colon Cancer: Alliance (Cancer and Leukemia Group B) 9581 and 89803.
Donna Niedzwiecki, Rian M Hasson, Heinz-Josef Lenz, Cynthia Ye, Mark Redston, Thomas A Colacchio

Oncologist· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness and clinical efficacy of biliary stents in patients undergoing neoadjuvant therapy for pancreatic adenocarcinoma in a randomized controlled trial.
Timothy B Gardner, Chad C Spangler, Katerina L Byanova, Gregory H Ripple, Matthew J Rockacy, Thomas A Colacchio

Gastrointest Endosc· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association Between Results of a Gene Expression Signature Assay and Recurrence-Free Interval in Patients With Stage II Colon Cancer in Cancer and Leukemia Group B 9581 (Alliance).
Donna Niedzwiecki, Wendy L Frankel, Alan P Venook, Xing Ye, Paula N Friedman, Thomas Anthony Colacchio

J Clin Oncol· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic characterization of patient-derived xenograft models established from fine needle aspirate biopsies of a primary pancreatic ductal adenocarcinoma and from patient-matched metastatic sites.
Robert J Allaway, Dawn A Fischer, Francine B de Abreu, Timothy B Gardner, Stuart R Gordon, Thomas A Colacchio

Oncotarget· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Invited commentary.
Thomas A Colacchio

J Am Coll Surg· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of neoadjuvant chemoradiation on pancreatic cancer-associated diabetes mellitus.
Timothy B Gardner, Nigeen Hessami, Kerrington D Smith, Gregory H Ripple, Richard J Barth, Thomas A Colacchio

Pancreas· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular profiling of appendiceal epithelial tumors using massively parallel sequencing to identify somatic mutations.
Xiaoying Liu, Kabir Mody, Francine B de Abreu, J Marc Pipas, Jason D Peterson, Thomas A Colacchio

Clin Chem· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Invited commentary.
Thomas A Colacchio

J Am Coll Surg· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pancreatic cyst prevalence and the risk of mucin-producing adenocarcinoma in US adults.
Timothy B Gardner, Lisa M Glass, Kerrington D Smith, Gregory H Ripple, Richard J Barth, Thomas A Colacchio

Am J Gastroenterol· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Documenting the natural history of patients with resected stage II adenocarcinoma of the colon after random assignment to adjuvant treatment with edrecolomab or observation: results from CALGB 9581.
Donna Niedzwiecki, Monica M Bertagnolli, Robert S Warren, Carolyn C Compton, Nancy E Kemeny, Thomas A Colacchio

J Clin Oncol· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microsatellite instability and loss of heterozygosity at chromosomal location 18q: prospective evaluation of biomarkers for stages II and III colon cancer--a study of CALGB 9581 and 89803.
Monica M Bertagnolli, Mark Redston, Carolyn C Compton, Donna Niedzwiecki, Robert J Mayer, Thomas A Colacchio

J Clin Oncol· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of initiating a multidisciplinary care clinic on access and time to treatment in patients with pancreatic adenocarcinoma.
Timothy B Gardner, Richard J Barth, Bassem I Zaki, Brian R Boulay, Margit M McGowan, Thomas A Colacchio

J Oncol Pract· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction therapy for poor-prognosis anal canal carcinoma: a phase II study of the cancer and Leukemia Group B (CALGB 9281).
Neal J Meropol, Donna Niedzwiecki, Brenda Shank, Thomas A Colacchio, John Ellerton

J Clin Oncol· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of neoadjuvant therapy on local recurrence after resection of pancreatic adenocarcinoma.
Sarah E Greer, J Marc Pipas, John E Sutton, Bassem I Zaki, Michael Tsapakos, Thomas A Colacchio

J Am Coll Surg· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Docetaxel/Gemcitabine followed by gemcitabine and external beam radiotherapy in patients with pancreatic adenocarcinoma.
J Marc Pipas, Richard J Barth, Bassem Zaki, Michael J Tsapakos, Arief A Suriawinata, Thomas A Colacchio

Ann Surg Oncol· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis